XORTX Therapeutics Inc Capital Reinvestment Ratio

Latest as of December 2020: 0.00x

XORTX Therapeutics Inc capital reinvestment ratio. XORTX Therapeutics Inc (XRTX) has a Capital Reinvestment Ratio of 0.00x as of December 2020, meaning it reinvests 0% of its operating cash flow (CA$1.57 Million) in capital expenditures (CA$2.84K). Check XRTX total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

CA$1.57 Million

CAD

Capital Expenditures

CA$2.84K

CAD

Data as of

Dec 2020

Most recent filing

Capital Reinvestment Ratio of XORTX Therapeutics Inc (2017–2017)

Capital reinvestment ratio of XORTX Therapeutics Inc from 2017 to 2017. This chart tracks XORTX Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore XORTX Therapeutics Inc (XRTX) net asset momentum to track the company's year-over-year net asset growth rate.

XORTX Therapeutics Inc Capital Reinvestment Ratio by Year (2017–2017)

XORTX Therapeutics Inc capital reinvestment ratio by year from 2017 to 2017. For the full cash flow conversion analysis, see XRTX cash flow conversion.

Year	Reinvestment Ratio	Operating CF (CAD)	Capital Expenditures	YoY Change
2017	0.01x	CA$91.17K	CA$1.17K	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow